Growth inhibitory activity of lemnabourside on human prostate cancer cells

Life Sciences

Volumn 70, Issue 7, 2002, Pages 843-853

  Liu, W K ^a,c   Wong, N L Y ^a   Huang, H M ^a   Ho, J K C ^a   Zhang, W H ^b   Che, C T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b HONG KONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Hong Kong)

^c and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

5 Reductase; Apoptosis; Human prostate carcinoma cell lines; Lemnabourside

Indexed keywords

ACID PHOSPHATASE; ANDROGEN; ANDROGEN RECEPTOR; ANDROSTANOLONE; ANTIGEN; CASPASE 3; LEMNABOURSIDE; NEPHTHEA CHABROLI; PROTEIN BCL 2; STEROID 5ALPHA REDUCTASE; STEROID 5ALPHA REDUCTASE INHIBITOR; TESTOSTERONE; THYMIDINE; TRITIUM; UNCLASSIFIED DRUG;

ANTIGEN SPECIFICITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER INHIBITION; CELL PROLIFERATION; CHEMICAL STRUCTURE; CONTROLLED STUDY; CORAL; DOSE RESPONSE; ENZYME INHIBITION; FLOW CYTOMETRY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HOMOGENATE; HUMAN; HUMAN CELL; IC 50; IMMUNOFLUORESCENCE MICROSCOPY; MARKER GENE; PROSTATE;

ACID PHOSPHATASE; ADENOCARCINOMA; ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL DIVISION; DITERPENES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; GLYCOSIDES; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, ANDROGEN; TESTOSTERONE 5-ALPHA-REDUCTASE; TUMOR CELLS, CULTURED;

ALCYONACEA; ANTHOZOA;

EID: 0037016552     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01457-6     Document Type: Article

References (29)

1. Combating prostate cancer
2. Multiple G1 regulatory elements control the androgen-dependent proliferation of prostatic carcinoma cells
3. Recent advances in chemoprevention of cancer
4. Testosterone and 5 alpha-dihydrotestosterone interact differently with the androgen receptor to enhance transcription of the MMTV-CAT reporter gene
5. Characterization of 5alpha-reductase gene expression in stroma and epithelium of human prostate
6. Vitamin D receptor content and transcriptional activity do not fully predict antiproliferative effects of vitamin D in human prostate cancer cell lines
7. Silibinin decreases prostate-specific antigen with cell growth inhibition via G1 arrest, leading to differentiation of prostate carcinoma cells: Implications for prostate cancer intervention
8. The expression of prostatic acid phosphatase is transcriptionally regulated in human prostate carcinoma cells
9. Expression of human prostatic acid phosphatase correlates with androgen-stimulated cell proliferation in prostate cancer cell lines
10. Steroid-independent activation of androgen receptor in androgen-independent prostate cancer; A possible role for the MAP kinase signal transduction pathway?
11. In vivo and in vitro approaches to study metastasis in human prostatic cancer
12. Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity
13. Cloning, expression and characterization of rhesus macaque types 1 and 2 5alpha-reductase: Evidence for mechanism-based inhibition by finasteride
14. Comparison of finasteride (Proscar), a 5 alpha reductase inhibitor, and various commercial plant extracts in in vitro and in vivo 5 alpha reductase inhibition
15. Azasteroids as inhibitors of testosterone 5 alpha-reductase in mammalian skin
16. A novel diterpene glycoside from the soft coral of lemnalia bournei
17. Cytotoxicity of Sinococuline
18. Anti-proliferative effect of ginseng saponins on human prostate cancer cell line
19. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
20. Regional distribution of 5alpha-reductase type 1 and type 2 mRNA, along the human epididymis
21. Polymerase chain reaction-based mRNA quantification using an internal standard: Analysis of oncogene expression
22. Upregulation of CASP genes in human tumor cells undergoing etoposide-induced apoptosis
23. Activation of Rb and decline in androgen receptor protein precede retinoic acid-induced apoptosis in androgen-dependent LNCaP cells and their androgen-independent derivative
24. Androgenic Induction of Prostate-specific Antigen Gene Is Repressed by Protein-Protein Interaction between the Androgen Receptor and AP-1/c-Jun in the Human Prostate Cancer Cell Line LNCaP
25. Effects of 5 alpha-dihydrotestosterone (DHT) on the transcription of nm23 and c-myc genes in human prostatic LNCaP cells
26. Induction of apoptosis and altered nuclear/cytoplasmic distribution of the androgen receptor and prostate-specific antigen by 1alpha,25-dihydroxyvitamin D3 in androgen-responsive LNCaP cells
27. Thalidomide up-regulates prostate-specific antigen secretion from LNCaP cells
28. Steroidal and non-steroidal inhibitors of steroid 5α-reductase
29. FCE 28260, a new 5 alpha-reductase inhibitor: In vitro and in vivo effects